TY - JOUR
T1 - MiR-449a inhibits cell proliferation, migration, and inflammation by regulating high-mobility group box protein 1 and forms a mutual inhibition loop with Yin Yang 1 in rheumatoid arthritis fibroblast-like synoviocytes
AU - Cai, Yongsong
AU - Jiang, Congshan
AU - Zhu, Jialin
AU - Xu, Ke
AU - Ren, Xiaoyu
AU - Xu, Lin
AU - Hu, Peijing
AU - Wang, Bo
AU - Yuan, Qiling
AU - Guo, Yuanxu
AU - Sun, Jian
AU - Xu, Peng
AU - Qiu, Yusheng
N1 - Publisher Copyright:
© 2019 The Author(s).
PY - 2019/6/3
Y1 - 2019/6/3
N2 - Background: We previously found that high-mobility group box protein 1 (HMGB1) promoted cell proliferation, migration, invasion, and autophagy in rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS), but little is known about its regulatory mechanism. The aim of this study was to investigate the regulatory mechanism of HMGB1 at the posttranscription level. Methods: Real-time qPCR, CCK-8 cell proliferation assay, transwell cell migration assay, enzyme-linked immunosorbent assay (ELISA), and western blotting were used in this study. The targeting relationship between miRNA and mRNA was presented by the luciferase reporter assay. Results: MiR-449a was downregulated in RA synovial tissue and inhibited RA-FLS proliferation, migration, and IL-6 production. MiR-449a directly targeted HMGB1 and inhibited its expression. Yin Yang 1(YY1) negatively regulated miR-449a expression and formed a mutual inhibition loop in RA-FLS. MiR-449a inhibited TNFα-mediated HMGB1 and YY1 overexpression and IL-6 production. Conclusions: Our results reveal the regulatory mechanism of HMGB1 in RA and demonstrate that miR-449a is a crucial molecule in RA pathogenesis and a suitable candidate for miRNA replacement therapies in RA.
AB - Background: We previously found that high-mobility group box protein 1 (HMGB1) promoted cell proliferation, migration, invasion, and autophagy in rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS), but little is known about its regulatory mechanism. The aim of this study was to investigate the regulatory mechanism of HMGB1 at the posttranscription level. Methods: Real-time qPCR, CCK-8 cell proliferation assay, transwell cell migration assay, enzyme-linked immunosorbent assay (ELISA), and western blotting were used in this study. The targeting relationship between miRNA and mRNA was presented by the luciferase reporter assay. Results: MiR-449a was downregulated in RA synovial tissue and inhibited RA-FLS proliferation, migration, and IL-6 production. MiR-449a directly targeted HMGB1 and inhibited its expression. Yin Yang 1(YY1) negatively regulated miR-449a expression and formed a mutual inhibition loop in RA-FLS. MiR-449a inhibited TNFα-mediated HMGB1 and YY1 overexpression and IL-6 production. Conclusions: Our results reveal the regulatory mechanism of HMGB1 in RA and demonstrate that miR-449a is a crucial molecule in RA pathogenesis and a suitable candidate for miRNA replacement therapies in RA.
KW - Fibroblast-like synoviocytes
KW - High-mobility group box protein 1
KW - Inflammation
KW - miR-449a
KW - Proliferation
KW - Rheumatoid arthritis
UR - https://www.scopus.com/pages/publications/85066876627
U2 - 10.1186/s13075-019-1920-0
DO - 10.1186/s13075-019-1920-0
M3 - 文章
C2 - 31159863
AN - SCOPUS:85066876627
SN - 1478-6354
VL - 21
JO - Arthritis Research and Therapy
JF - Arthritis Research and Therapy
IS - 1
M1 - 134
ER -